KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Exchange Rate Effect: 2009-2023

Historic Exchange Rate Effect for Emergent BioSolutions (EBS) over the last 14 years, with Dec 2023 value amounting to -$1.2 million.

  • Emergent BioSolutions' Exchange Rate Effect was N/A to -$200,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 million, marking a year-over-year change of. This contributed to the annual value of -$1.2 million for FY2023, which is 340.00% down from last year.
  • According to the latest figures from FY2023, Emergent BioSolutions' Exchange Rate Effect is -$1.2 million, which was down 340.00% from $500,000 recorded in FY2022.
  • In the past 5 years, Emergent BioSolutions' Exchange Rate Effect ranged from a high of $500,000 in FY2022 and a low of -$1.2 million during FY2023.
  • Its 3-year average for Exchange Rate Effect is -$333,333, with a median of -$300,000 in 2021.
  • In the last 5 years, Emergent BioSolutions' Exchange Rate Effect soared by 300.00% in 2019 and then crashed by 350.00% in 2020.
  • Over the past 5 years, Emergent BioSolutions' Exchange Rate Effect (Yearly) stood at $400,000 in 2019, then tumbled by 350.00% to -$1.0 million in 2020, then skyrocketed by 70.00% to -$300,000 in 2021, then soared by 266.67% to $500,000 in 2022, then tumbled by 340.00% to -$1.2 million in 2023.